C G Kardinal
Overview
Explore the profile of C G Kardinal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
782
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kardinal C, Cole J
Ochsner J
. 2011 Jul;
2(1):10-3.
PMID: 21765655
Breast cancer is the most common invasive cancer in American women and is second only to carcinoma of the lung in cancer deaths. The results of the National Surgical Adjuvant...
2.
3.
Jatoi A, Foster N, Johnson P, Klee G, Quevedo J, MORTON R, et al.
Dis Esophagus
. 2004 Dec;
17(4):292-6.
PMID: 15569365
Eighty-five to 95% of esophageal cancer patients suffer dysphagia. Yet, few studies have focused on this symptom, and four 'myths' persist: (i) dysphagia cannot be measured; (ii) chemotherapy cannot palliate...
4.
Sloan J, Loprinzi C, Laurine J, Novotny P, Krook J, Oconnell M, et al.
J Clin Oncol
. 2001 Aug;
19(15):3539-46.
PMID: 11481361
Purpose: This article summarizes the third step of a research program to identify variables that supplement the predictive power of the the Eastern Cooperative Oncology Group (ECOG) performance status (PS)...
5.
Fisher B, Anderson S, Tan-Chiu E, Wolmark N, Wickerham D, Fisher E, et al.
J Clin Oncol
. 2001 Feb;
19(4):931-42.
PMID: 11181655
Purpose: Uncertainty about the relative worth of doxorubicin/cyclophosphamide (AC) and cyclophosphamide/methotrexate/fluorouracil (CMF), as well as doubt about the propriety of giving tamoxifen (TAM) with chemotherapy to patients with estrogen receptor-negative...
6.
Perez E, Hillman D, Stella P, Krook J, Hartmann L, Fitch T, et al.
Cancer
. 2000 Jan;
88(1):124-31.
PMID: 10618614
Background: This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m(2) by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every...
7.
Fisher B, Anderson S, DeCillis A, Dimitrov N, Atkins J, Fehrenbacher L, et al.
J Clin Oncol
. 1999 Nov;
17(11):3374-88.
PMID: 10550131
Purpose: In 1989, the National Surgical Adjuvant Breast and Bowel Project initiated the B-22 trial to determine whether intensifying or intensifying and increasing the total dose of cyclophosphamide in a...
8.
Fisher B, Dignam J, Wolmark N, Wickerham D, Fisher E, Mamounas E, et al.
Lancet
. 1999 Jun;
353(9169):1993-2000.
PMID: 10376613
Background: We have shown previously that lumpectomy with radiation therapy was more effective than lumpectomy alone for the treatment of ductal carcinoma in situ (DCIS). We did a double-blind randomised...
9.
Kardinal C, Veith R
J La State Med Soc
. 1999 May;
151(4):198-201.
PMID: 10234895
The results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (BCPT) were released in April 1998. In that trial, 13,388 women who were at...
10.
Whiting R, Kardinal C
J La State Med Soc
. 1999 May;
151(4):171-3.
PMID: 10234890
The Louisiana Cancer and Lung Trust Fund Board, begun in 1980, continues to move forward in its mission in cancer research and tobacco control. During the last year, the board...